OMAR ALI | FORMER ADVISER NICE & HEAD OF PAYERS VERPORA
VERPORA

Omar Ali BSc(Hons)Pharm DipClinPharm MRCPharm ACPP
Former Government Adviser NICE
Head of Payers, Verpora

  As Head of Payers at Verpora, Omar works with pharmaceutical and life sciences organisations to shape access strategy, value communication and pricing negotiations across global markets. Drawing on more than 30 years of experience from both government & commercial payer perspectives (including 10years as a Government Payer at NICE), he supports clients in navigating payer expectations and developing practical access strategies. Omar leads Verpora’s global network of more than 150 current/former payers across EU, US, EMEA, APAC and LATAM, supporting both the Access Strategy and Business Insights arms of the business. Over the past 20 years he has supported more than 100 pharmaceutical & life sciences organisations, translating payer expectations into actionable strategies that strengthen value propositions, improve negotiation readiness and support sustainable patient access. Over the last few years, he has worked in partnership with a Washington based Law Firm to prepare, develop and support 7x US pharmaceutical manufacturers across both 1st round & 2nd round of CMS/Medicare Drug Price Negotiations. He hosts the Payer Exchange Podcast (Spotify & Apple Music) and leads Verpora’s IC Fireside Chat (www.verpora.com) video series, exploring real-world access and pricing challenges with payers and industry leaders. He is also a frequent keynote speaker on innovative contracting and value-based agreements at international conferences and senior industry forums, including the American Managed Care Pharmacy Association AMCP (US), World Orphan Drug Congress WODC (Amsterdam), RWE & Pricing Conferences (London & Frankfurt), Value Based & Innovative Contracting in Oncology (Dubai) and US commercial contracting leadership events such as Rainmaker (Model-N, Austin Texas) and PPIC (Eversana/Navlin, Orlando) all in the last 12months!

He has been a visiting lecturer on payer value frameworks and innovative contracting methodologies at several universities, including Portsmouth, UCL London, Lisbon School of Pharmacy and Barcelona Business School. He has authored more than 35 publications, including his PhD thesis paper, Establishing the cost of implementing a performance-based managed entry agreement for a hypothetical CAR T-cell therapy commissioned by Catapult/Innovate UK. Omar brings a distinctive understanding of payer decision-making, helping life sciences teams pressure-test value propositions and explore access strategies and pricing corridors in a safe, constructive environment.